Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.

For prostate biopsy planning, multiparametric MRI has relatively low specificity particularly for PI-RADS 3 and PI-RADS 4 ...

Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...

A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, and the risk varies depending on age and race.

Four brothers who were all diagnosed with prostate cancer within six months of each other said going through treatment ...